Glaxo Takes Another Shot At China: A Joint Venture to Make And Sell Its Priorix Vaccine
• By PharmAsia News
In its second vaccine-related collaboration with a Chinese company this year, GlaxoSmithKline announced on Oct. 6 that it is teaming up with Jiangsu Walvax Biotech to develop and manufacture pediatric vaccines in the fast-growing Asian nation
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
